We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Automated UV-C Device Reduces Pathogens in Contaminated Rooms

By HospiMedica International staff writers
Posted on 30 Dec 2010
An automated ultraviolet light (UV)-C device significantly reduced nosocomial pathogens in hospital rooms. More...
UV-C is a shortwave UV that includes germicidal ultraviolet--200 nm - 320 nm wavelengths--used for air, surface, and water disinfection.

A hospital study evaluated the ability of Lumalier's (Memphis, TN, USA) automated UV device, Tru-D, to decontaminate patient rooms infected with methicillin resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), Clostridium difficile, and a multidrug resistant (MDR) strain of Acinetobacter baumannii.

Evaluation of the device took place at the University of North Carolina Health Care (Chapel Hill, NC, USA from January 21 through September 21, 2009. During phase 1 trial, MRSA, VRE, A. baumannii, and C. difficile samples were placed behind objects and within line-of-sight of the UV-C device. UV-C reduced vegetative bacteria counts by more than 99.9% within 15 minutes. C. difficile spore reduction was 99.8% within 50 minutes.

For phase 2, isolation rooms for MRSA or VRE- infected patients were sampled. After 15 minutes of UV-C exposure, there was a significant decrease in total colony forming units (CFUs) (384 vs. 19), in positive MRSA samples (81 vs. 2), and in MRSA counts per plate (37 vs. 2). Similar reductions were recorded for VRE.

In previous studies using manual disinfection, patients hospitalized in rooms previously occupied by infected individuals experienced a significantly higher rate of acquiring infectious organisms from environmental surfaces. Trials using fluorescent markers revealed that only 48% of environmental surfaces are actually disinfected during terminal cleaning.

The hospital study of the TruD demonstrated that the environment-friendly UV-C device is effective in significantly reducing pathogens on all environmental surfaces, both line-of sight and shadowed. The study was published in the October 2010 issue of Infection Control and Hospital Epidemiology.

Related Links:

Lumalier
University of North Carolina Health Care



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.